Erythropoietin's Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons

EPO attenuates neuronal loss after oxygen-glucose deprivation in a βcR-dependent fashion. This receptor holds immense clinical promise as a target for pharmacotherapies treating spinal cord ischemic injury.